Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Acute Kidney Injury | Case report

IgG4-related kidney disease (IgG4-RKD) with membranous nephropathy as its initial manifestation: report of one case and literature review

Authors: Nan-Nan Zhang, Yan-Yun Wang, Ling-Xin Kong, Wan-Zhong Zou, Bao Dong

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

IgG4-related disease (IgG4-RD) often affects multiple organs and tissues, especially the kidneys, and is characterized by interstitial nephritis, obstructive nephropathy, and in rare cases glomerulopathy (including membranous nephropathy).

Case presentation

In this article, we report a patient with nephrotic syndrome as the only initial manifestation. Membranous nephropathy was confirmed by renal biopsy, but without any renal interstitial lesions. The nephrotic syndrome completely resolved after treatment with immunosuppressants but recurred after drug withdrawal, which was accompanied by acute kidney injury. Ultimately, IgG4-related interstitial nephritis with membranous nephropathy was confirmed by a second renal biopsy. After routine administration of steroids and cyclophosphamide, renal function returned to normal after 2 months, and nephrotic syndrome was ameliorated after 5 months.

Conclusion

Special attention should be paid to this rare condition in the clinical setting. In patients with membranous nephropathy (MN) that is accompanied by multi-system damage, impaired renal function, elevated IgG4 levels (absolute or relative value), negative PLA2R, and/or renal interstitial plasma cell infiltration, the possibility of IgG4-related kidney disease (IgG4-RKD) should be carefully assessed.
Literature
1.
go back to reference Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.CrossRef Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.CrossRef
2.
go back to reference Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol. 2008;14:3948–55.CrossRef Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol. 2008;14:3948–55.CrossRef
3.
go back to reference Kawano M, Saeki T. IgG4-related kidney disease-an update. Curr Opin Nephrol Hypertens. 2015;24:193–201.CrossRef Kawano M, Saeki T. IgG4-related kidney disease-an update. Curr Opin Nephrol Hypertens. 2015;24:193–201.CrossRef
4.
go back to reference Zheng K, Teng F, Li X-M. Immunoglobulin G4-related kidney disease:Pathogenesis,diagnosis,and treatment. Chronic Dis Transl Med. 2017;3:138–47.CrossRef Zheng K, Teng F, Li X-M. Immunoglobulin G4-related kidney disease:Pathogenesis,diagnosis,and treatment. Chronic Dis Transl Med. 2017;3:138–47.CrossRef
5.
go back to reference Saeki T, Nishi S, Imai N, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis[J]. Kidney Int. 2010;78(10):1016–23.CrossRef Saeki T, Nishi S, Imai N, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis[J]. Kidney Int. 2010;78(10):1016–23.CrossRef
6.
go back to reference Yamaguchi Y, Kanetsuna Y, Honda K, et al. Characteristics tubulointerstitial nephritis in IgG4-related disease[J]. Hum Pathol. 2012;43(4):536–49.CrossRef Yamaguchi Y, Kanetsuna Y, Honda K, et al. Characteristics tubulointerstitial nephritis in IgG4-related disease[J]. Hum Pathol. 2012;43(4):536–49.CrossRef
7.
go back to reference Lin W, Lu S, Chen H, et al. Clinical characteristics of immunoglobulin G4-related disease:a prospective study of 118 Chinese patients. Rheumatol(Oxford). 2015;54:1982–90.CrossRef Lin W, Lu S, Chen H, et al. Clinical characteristics of immunoglobulin G4-related disease:a prospective study of 118 Chinese patients. Rheumatol(Oxford). 2015;54:1982–90.CrossRef
8.
go back to reference Shoji S, Nakano M, Usui Y. IgG4-related infl ammatory pseudotumor of the kidney[J]. Int J Urol. 2010;17(4):389–90.CrossRef Shoji S, Nakano M, Usui Y. IgG4-related infl ammatory pseudotumor of the kidney[J]. Int J Urol. 2010;17(4):389–90.CrossRef
9.
go back to reference Zheng K, Li XM, Cai JF, Wen YB. Analysis on urinary system lesions of IgG4-related disease. Chin J Nephrol. 2012;28:937–42. Zheng K, Li XM, Cai JF, Wen YB. Analysis on urinary system lesions of IgG4-related disease. Chin J Nephrol. 2012;28:937–42.
10.
go back to reference Chen G, Zheng K, Ye WL, et al. Clinical feature of renal impairment caused by IgG4 related disease with renal and urinary lesions. Chin J Nephrol. 2015;31:7–12. Chen G, Zheng K, Ye WL, et al. Clinical feature of renal impairment caused by IgG4 related disease with renal and urinary lesions. Chin J Nephrol. 2015;31:7–12.
11.
go back to reference Cornell LD. IgG4-related kidney disease. Curr Opin Nephrol Hypertens. 2012;21:279–88.CrossRef Cornell LD. IgG4-related kidney disease. Curr Opin Nephrol Hypertens. 2012;21:279–88.CrossRef
12.
go back to reference Machado MAC, Silva JAF, Garcia EA, Allemann N. Ultrasound parameters of normal lacrimal sac and chronic dacryocystitis. Arq Bras Oftalmol. 2017;80(3):172–5.CrossRef Machado MAC, Silva JAF, Garcia EA, Allemann N. Ultrasound parameters of normal lacrimal sac and chronic dacryocystitis. Arq Bras Oftalmol. 2017;80(3):172–5.CrossRef
13.
go back to reference Alexander MP, Larsen CP, Gibson IW, et al. Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int. 2013;83:455–62.CrossRef Alexander MP, Larsen CP, Gibson IW, et al. Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int. 2013;83:455–62.CrossRef
14.
go back to reference Khosroshahi A, Ayalon R, Beck LH, Salant DJ, Bloch DB, Stone JH. IgG4-related disease is not associated with antibody to the phospholipase A2 receptor. Int J Rheumatol. 2012;2012:139409.CrossRef Khosroshahi A, Ayalon R, Beck LH, Salant DJ, Bloch DB, Stone JH. IgG4-related disease is not associated with antibody to the phospholipase A2 receptor. Int J Rheumatol. 2012;2012:139409.CrossRef
15.
go back to reference Wada Y, Saeki T, Yoshita K, et al. Development of IgG4-related disease in a patient diagnosed with idiopathic membranous nephropathy. Clin Kidney J. 2013;6:486–90.CrossRef Wada Y, Saeki T, Yoshita K, et al. Development of IgG4-related disease in a patient diagnosed with idiopathic membranous nephropathy. Clin Kidney J. 2013;6:486–90.CrossRef
16.
go back to reference Dai H, Zhang H, He Y. Diagnosic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation ofidiopathic and secondary membranous nephropathy:an updated meta-analysis[J]. Sci Rep. 2015;5:8803.CrossRef Dai H, Zhang H, He Y. Diagnosic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation ofidiopathic and secondary membranous nephropathy:an updated meta-analysis[J]. Sci Rep. 2015;5:8803.CrossRef
17.
go back to reference Khosroshahi A, Stone JH. Treatment approaches to IgG4-related syetemic disease[J]. Curr Opin Rheumatol. 2011;23(1):67–71.CrossRef Khosroshahi A, Stone JH. Treatment approaches to IgG4-related syetemic disease[J]. Curr Opin Rheumatol. 2011;23(1):67–71.CrossRef
18.
go back to reference Saida Y, Homma M-N, Hama H, et al. A case of IgG4-related tubulointerstitial nephritis showing the progression of renal dysfunction after a cure for autoimmue pancreatitis. Nihon Jinzo Gakkai Shi. 2010;52(1):73–9.PubMed Saida Y, Homma M-N, Hama H, et al. A case of IgG4-related tubulointerstitial nephritis showing the progression of renal dysfunction after a cure for autoimmue pancreatitis. Nihon Jinzo Gakkai Shi. 2010;52(1):73–9.PubMed
Metadata
Title
IgG4-related kidney disease (IgG4-RKD) with membranous nephropathy as its initial manifestation: report of one case and literature review
Authors
Nan-Nan Zhang
Yan-Yun Wang
Ling-Xin Kong
Wan-Zhong Zou
Bao Dong
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1419-6

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.